Digital Therapeutics Market Overview:
According to IMARC Group latest report titled “Digital Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a comprehensive analysis of the industry, which comprises insights on digital therapeutics market trends. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global digital therapeutics market reached a value of US$ 4.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 13.4 Billion by 2027, exhibiting a CAGR of 21.7% during 2022-2027.
Digital therapeutics delivers evidence-based therapeutic interventions to patients. It is delivered to patients through software solutions that replaces or complements the existing treatment of a disease. These software applications can be used independently or in combination with devices, medications, or any other therapies to provide patient care and health outcomes. It is different from the digital health market in a way that it must be approved by regulatory bodies and displaying proof-of-concept is at the core of their model.
Get a Free Sample Copy of this Report: https://www.imarcgroup.com/digital-therapeutics-market/requestsample
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
The global market is majorly driven by the rising incidences of chronic diseases. In line with this, the increasing adoption of smartphone and tablets among the masses are significantly contributing to the market growth across the globe. Furthermore, the growing popularity of healthcare apps is positively influencing the market growth. Apart from this, the rising need to control healthcare costs and increasing an enhanced focus on preventive healthcare is catalyzing the market growth. Moreover, growing investments in digital therapeutics by the key market players are propelling the market growth across the globe. Besides this, the increasing awareness about the benefits of digital therapeutics is creating a positive outlook for the market. Additionally, the inclination of pharmaceutical companies to integrate digital therapeutics with their drug products is providing a boost to the market growth worldwide.
Competitive Landscape with Key players:
The report has also analysed the competitive landscape of the market with some of the key players being.
- 2Morrow Inc.
- Canary Health Inc.
- Click Therapeutics Inc.
- Mango Health Inc.
- Noom Health Inc.
- Omada Health Inc.
- Pear Therapeutics, Inc.
- Propeller Health
- Teladoc Health Inc.
- Voluntis Inc.
- WellDoc Inc
Digital Therapeutics Market Segmentation:
Our report has categorized the market based on region, application and end use.
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800